APA

Wei X., Wu J., Zhao G., Galdamez J., Lele S. M., Wang X., Liu Y., Soni D. M., Purdue P. E., Mikuls T. R., Goldring S. R. & Wang D. (20190716). Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis. : Molecular pharmaceutics.

Chicago

Wei Xin, Wu Jianbo, Zhao Gang, Galdamez Josselyn, Lele Subodh M, Wang Xiaoyan, Liu Yanzhi, Soni Dhruvkumar M, Purdue P Edward, Mikuls Ted R, Goldring Steven R and Wang Dong. 20190716. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis. : Molecular pharmaceutics.

Harvard

Wei X., Wu J., Zhao G., Galdamez J., Lele S. M., Wang X., Liu Y., Soni D. M., Purdue P. E., Mikuls T. R., Goldring S. R. and Wang D. (20190716). Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis. : Molecular pharmaceutics.

MLA

Wei Xin, Wu Jianbo, Zhao Gang, Galdamez Josselyn, Lele Subodh M, Wang Xiaoyan, Liu Yanzhi, Soni Dhruvkumar M, Purdue P Edward, Mikuls Ted R, Goldring Steven R and Wang Dong. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis. : Molecular pharmaceutics. 20190716.